Drawing for BELINAL

USPTO serial 98539811

BELINAL

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
DUNN, MADELINE R
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with BELINAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew D. Bochner

Andrew D. Bochner Bochner PLLC1040 Avenue of the Americas15th FloorNew York, NY 10018

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredient derived from silver fir wood for use in the manufacture of pharmaceuticalsACTIVE—
003Cosmetics; Beauty care cosmetics; Cosmetic creams; bath soap; perfumery; essential oils; Hair lotions; Dentifrices; Cosmetic creams for skincare; Cosmetic lotions for skincare; Cosmetic preparations for slimming purposes; Beauty masks; Anti wrinkle creams; Creams for atopic skin; Moisturizing creams; Anti-aging creams; Shaving creams; Body creams; Eye creams; Cosmetic base cream for skincare; Face creams for cosmetic use; Hand creams; Nail creams; Cuticle creams; Cosmetic suntan lotion; Cold cream; Lip cream; Skin creams; Hair creams; Essential oil-based creams for aromatherapy use; Skin cleansing creams; Depilatory creams; Bath creams for washing skin; Exfoliant creams; Body mask cream; Anti-aging creams; Anti-freckle creams; Non-medicated toiletry preparations, namely, soaps; Detergent soapACTIVE—
005Pharmaceutical and veterinary preparations, namely, capsules, powders, tablets, creams and lotions for the treatment of cardiovascular disorders, dermatological disorders, diabetes, increased cholesterol, and issues with concentration; Sanitary preparations for medical purposes; Dietetic preparations adapted for medical or veterinary use; Infant formula; Dietary supplements for humans and animals; Plasters for medical purposes; dressings for medical use, namely, adhesive bandages; Disinfectants; Pharmaceutical preparations for skin care; Medical preparations, namely, capsules, powders, tablets, creams, lotions for the treatment of cardiovascular disorders, dermatological disorders, diabetes, increased cholesterol, and issues with concentration; diet pills; Dietary and nutritional supplements containing antioxidants, in the form of pills; Dietary supplements in the form of capsules; Medicated skin care preparations, namely, creams; Medicated creams for atopic skin; Medicated face cream; Medicated babies' creams for treating diaper rash; Medicated baby nappy cream for treating atopic skin; Medicated body creams for treating atopic skin; Medicated pain relieving creams for skin; Medicated protective skin creams; Medical therapeutic skin creams; Medicated pharmaceutical moisturizing creams; Pharmaceutical preparations, namely acne creams; Medicated cold cream for medical use; Medicated hand creams for medical use; Medicated foot creams; Medicated lip creams; Medicated skin care creams for medical use; Anti-fungal creams for medical purposes; Medicated creams for application after exposure to the sun; Unit dose capsules sold empty for pharmaceutical use for the treatment of cardiovascular disorders, dermatological disorders, diabetes, increased cholesterol, and issues with concentration; Pharmaceutical preparations, namely, cachets for pharmaceutical purposes for the treatment of cardiovascular disorders, dermatological disorders, diabetes, increased cholesterol, and issues with concentration; Dietary food supplements; Nutritional supplements; Vitamin supplements; Dietary amino acid supplements; Anti-oxidant food supplements; Mineral food supplements; Vitamin preparations; Food supplements for dietetic use; Herbal extracts, other than essential oils, for medical purposes; Medicinal drinks; Dietary fiber for treating constipation; Candy, medicated; Medicated candies; Dietetic foods, namely, cereals adapted for medical use; Medicinal oils, other than essential oils; Medicinal herbs; Medicinal tea; Amino acids for medical purposes; Dietetic food supplements; Dietetic supplements adapted for medical use, namely, vitamins, minerals, herbal extracts, other than essential oils, silver fir wood extracts, amino acids, enzymes; Creams for dermatological useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Jul 14, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 19, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 21, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 23, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 18, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 27, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 27, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Aug 27, 2025CNSLSUSPENSION LETTER WRITTEN—
Jun 17, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 17, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 17, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 5, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 7, 2025ALIEASSIGNED TO LIE—
Feb 26, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 26, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2024DOCKASSIGNED TO EXAMINER—
Nov 5, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance